Kallikrein 2 anticorps (Middle Region)
Aperçu rapide pour Kallikrein 2 anticorps (Middle Region) (ABIN632433)
Antigène
Voir toutes Kallikrein 2 (KLK2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- KLK2 antibody was raised against the middle region of KLK2
-
Purification
- Affinity purified
-
Immunogène
- KLK2 antibody was raised using the middle region of KLK2 corresponding to a region with amino acids KHQSLRPDEDSSHDLMLLRLSEPAKITDVVKVLGLPTQEPALGTTCYASG
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KLK2 Blocking Peptide, (ABIN939805), is also available for use as a blocking control in assays to test for specificity of this KLK2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KLK2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Kallikrein 2 (KLK2)
-
Autre désignation
- KLK2
-
Sujet
- Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin.
-
Poids moléculaire
- 25 kDa (MW of target protein)
-
Pathways
- Système du Complément
Antigène
-